Article

Current Pain and Headache Reports

, Volume 7, Issue 6, pp 466-474

First online:

Current and potential future drug therapies for tension-type headache

  • Sait AshinaAffiliated withDanish Headache Center, University of Copenhagen and Department of Neurology, Glostrup University Hospital
  • , Messoud AshinaAffiliated withDanish Headache Center, University of Copenhagen and Department of Neurology, Glostrup University Hospital

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Tension-type headache is a common primary headache with tremendous socioeconomic impact. Establishment of an accurate diagnosis is important before initiation of any pharmacologic therapy. Simple analgesics and nonsteroidal anti-inflammatory drugs are the mainstays of treatment of episodic tension-type headache. The tricyclic antidepressant amitriptyline is the drug of choice in the preventive treatment of chronic tension-type headache. Progress in basic neuroscience has emphasized the importance of nitric oxide inhibition and N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methylisoxasole-4-propionic acid receptor antagonism in the treatment of chronic pain. It has been demonstrated that inhibition of nitric oxide is effective in chronic tension-type headache. These interesting data indicate that more specific and effective treatment possibilities will emerge in the future.